Llamas nanobodies may provide protection against COVID-19
Share on PinterestResearchers discovered that “super immunity” nanobodies from llamas may offer protection against viruses that cause COVID-19 and similar...
Social Impact
Highly Contagious BA.5 Variant Becomes Dominant In U.S. As Covid Cases Rise
Topline The highly transmissible BA.5 omicron subvariant is now the dominant coronavirus strain in the U.S., accounting for nearly 54%...
Covid-19 Vaccines and Variants News: Live Updates
In the early 1990s, long before P.P.E., N95 and asymptomatic transmission became household terms, federal health officials issued guidelines for...
COVID-19 was third-leading US cause of death between March 2020 and October 2021
COVID-19 was the third-leading cause of death in the U.S. between March 2020 and October 2021, according to an analysis...
CDC: BA.5 is dominant COVID-19 strain nationwide
The BA.5 omicron subvariant is now the dominant COVID-19 strain across the nation, while accounting for almost half of infections in...
COVID-19 was third-leading US cause of death in 2020 and 2021
COVID-19 was the third leading cause of death in the U.S. between March 2020 and October 2021, according to an...
Coronavirus in Colorado: COVID-19 updates for July 4-July 10, 2022
More than 1,543,200 people in Colorado have tested positive for COVID-19 and more than 64,700 have been hospitalized as of...
COVID-19 was third leading cause of death in the United States in both 2020 and 2021
Media AdvisoryTuesday, July 5, 2022 What COVID-19 was the third leading cause of death in the United States between March...
‘All-In-One’ Vaccine Could Protect Against Future Covid-19 Variants, Researchers Say
ToplineAn “all-in-one” vaccine currently in development could protect people from future Covid-19 variants, as well as SARS, MERS and new...
World’s Covid vaccine, drugs equity program set to wind down this fall
The ACT-Accelerator faced significant obstacles to get vaccines to low- and middle-income countries, but it eventually succeeded in shipping over...